Your session is about to expire
← Back to Search
LAA Exclusion Device
AtriClip for Left Atrial Appendage Absent
N/A
Waitlist Available
Led By Elias Zias, MD
Research Sponsored by AtriCure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months or greater post-procedure
Awards & highlights
Study Summary
This trial will look at the long-term effects of two devices used to close off the left atrial appendage of the heart. The study is non-randomized and unblinded, meaning that doctors will know which device each patient has, and patients will not be randomly assigned to a group.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-months or greater post-procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months or greater post-procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Performance Endpoint
Primary Safety Endpoint
Secondary outcome measures
Device and Procedure long-term Safety
Long-term thromboembolic events
Performance
Trial Design
1Treatment groups
Experimental Treatment
Group I: AtriClip groupExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
AtriCure, Inc.Lead Sponsor
42 Previous Clinical Trials
17,395 Total Patients Enrolled
Elias Zias, MDPrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: AtriClip group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger